Health Catalyst (NASDAQ:HCAT) CEO Simeon Kohl Purchases 59,000 Shares of Stock

Health Catalyst, Inc. (NASDAQ:HCAT) CEO Simeon Kohl purchased 59,000 shares of the business’s stock in a transaction dated Monday, September 14th. The stock was bought at an average cost of $1.79 per share, for a total transaction of $105,610.00. Following the purchase, the chief executive officer owned 2,856,385 shares in the company, valued at $5,112,929.15. This trade represents a 2.11% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Health Catalyst Stock Up 0.6%

NASDAQ:HCAT opened at $1.73 on Thursday. The company has a quick ratio of 2.70, a current ratio of 2.70 and a debt-to-equity ratio of 1.51. Health Catalyst, Inc. has a 12-month low of $0.96 and a 12-month high of $3.62. The stock’s fifty day simple moving average is $1.90 and its 200-day simple moving average is $1.64. The firm has a market capitalization of $130.20 million, a P/E ratio of -0.47 and a beta of 1.53.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.04 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. Health Catalyst had a negative return on equity of 1.83% and a negative net margin of 90.61%.The business had revenue of $70.49 million during the quarter, compared to the consensus estimate of $69.09 million. Equities research analysts expect that Health Catalyst, Inc. will post -0.18 earnings per share for the current year.

Hedge Funds Weigh In On Health Catalyst

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Palogic Value Management L.P. acquired a new stake in shares of Health Catalyst in the 2nd quarter valued at about $9,796,000. Whetstone Capital Advisors LLC boosted its position in shares of Health Catalyst by 0.5% during the fourth quarter. Whetstone Capital Advisors LLC now owns 3,750,377 shares of the company’s stock worth $8,963,000 after buying an additional 19,027 shares during the period. BlackRock Inc. acquired a new position in shares of Health Catalyst during the second quarter worth about $3,654,000. Hsbc Holdings PLC bought a new position in shares of Health Catalyst during the second quarter worth about $809,000. Finally, Squarepoint Ops LLC grew its holdings in shares of Health Catalyst by 1,214.8% during the second quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock worth $796,000 after buying an additional 369,772 shares in the last quarter. 85.00% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently commented on HCAT shares. Wells Fargo & Company dropped their price objective on Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating on the stock in a research note on Thursday, August 13th. Citigroup dropped their price target on Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 11th. Weiss Ratings upgraded Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Tuesday, July 28th. Finally, Canaccord Genuity Group reissued a “hold” rating and set a $1.80 target price (down from $3.00) on shares of Health Catalyst in a research note on Thursday, August 20th. Three investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $2.45.

Health Catalyst Company Profile

Health Catalyst, Inc is a healthcare technology and data analytics company that helps healthcare organizations use data to improve clinical outcomes, operational performance and financial results. The company provides software, data management capabilities and professional services designed to support hospitals, health systems, medical groups and other healthcare providers.

Its offerings include the Health Catalyst Data Operating System, which integrates and organizes data from disparate clinical, financial and operational systems, as well as analytics applications for areas such as quality improvement, population health, cost management and care delivery.